Phase 1b Study of Menin-KMT2A Inhibitor Bleximenib in Combination with Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia with KMT2Ar or NPM1 Alterations Christian Recher , Jenny O'Nions , Ibrahim Aldoss , Ana Alfonso Pierola , Alicia Allred , Juan Manuel Alonso-Dominguez , Laura Barreyro , Pierre Bories , Martin Curtis , Nikki Daskalakis , Matteo Giovanni Della Porta , Hartmut Döhner , Amber D'Souza , James P. Dugan , Jordi Esteve Reyner , Matthew Exum , Amir T. Fathi , Pasquale L. Fedele , Lucille Ferrante , Stan Gaj , Sylvain Garciaz , Ana Garrido , Sara Garrido Paniagua , Christina Guttke , Emmanuel Gyan , Brett Hiebert , Elias Jabbour , Madlen Jentzsch , Hagop M. Kantarjian , Marina Konopleva , Jan Krönke , Min Chul Kwon , Christina Loefgren , Oliver Lomas , Valentina Mancini , Ioannis Mantzaris , Giovanni Martinelli , Daniel Morillo Giles , Joseph Murphy , Kathryn Packman , Cristina Papayannidis , Ulrike Philippar , Uwe Platzbecker , Sravanti Rangaraju , Christoph Röllig , Olga Salamero , Madhu Sanga , Tim Sauer , Emma Searle , Natalia Tovar , Trevor Tucker , Nicolas Vallet , Lachlin Vaughan , Gala Vega , Paresh Vyas , Andrew Wei Blood（2024）
AI 理解论文
溯源树
样例
